FI87199B - Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,2,5,6-tetrahydropyridin-3 -karboxialdoximderivat. - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,2,5,6-tetrahydropyridin-3 -karboxialdoximderivat. Download PDF

Info

Publication number
FI87199B
FI87199B FI870842A FI870842A FI87199B FI 87199 B FI87199 B FI 87199B FI 870842 A FI870842 A FI 870842A FI 870842 A FI870842 A FI 870842A FI 87199 B FI87199 B FI 87199B
Authority
FI
Finland
Prior art keywords
compound
formula
tetrahydropyridine
carbon atoms
salt
Prior art date
Application number
FI870842A
Other languages
English (en)
Finnish (fi)
Other versions
FI87199C (sv
FI870842A (fi
FI870842A0 (fi
Inventor
Emilio Toja
Giulio Galliani
Fernando Barzaghi
Carla Bonetti
Alina Butti
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT19565/86A external-priority patent/IT1191667B/it
Priority claimed from IT21157/86A external-priority patent/IT1196510B/it
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of FI870842A0 publication Critical patent/FI870842A0/fi
Publication of FI870842A publication Critical patent/FI870842A/fi
Publication of FI87199B publication Critical patent/FI87199B/fi
Application granted granted Critical
Publication of FI87199C publication Critical patent/FI87199C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (10)

1. Förfarande för framställning av terapeutiskt användbara 1,2,5,6-tetrahydropyridin-3-karboxialdoximer 5 med formeln I ^—CH=NOR' kNJ (I) R 10 väri R betecknar en väteatom, en rakkedjad, förgrenad eller cyklisk, mättad eller omättad alkylradikal med högst 8 kolatomer, vilken möjligen är substituerad med en karboxi-15 radikal eller med en alkoxikarbonylgrupp vars alkoxidel innehäller högst 8 kolatomer, eller R betecknar en bensyl-eller fenetylradikal, och R' betecknar en rakkedjad, mättad eller omättad alkylradikal med högst 8 kolatomer, 20 samt deras syraadditionssalter, känne- t e c k n a t därav, att a) en förening med formeln II eller ett sait därav
25 IT” CH0 kNJ (II) i R i vilken formel R har ovan angivna betydelse, omsätts med 30 en förening med formeln III eller med ett sait därav NH20R' j (III) i vilken formel R'x betecknar en väteatom eller en rakked-35 jad mättad eller omättad alkylradikal med högst 8 kolato- 29 87199 mer, för erhällande av en förening med formeln IA — CH=NOR \ ( Ia ^ ^ N ' 5 i R vilken förening vid behov omvandlas tili ett sait, och en förening med formeln IA, väri R^ icke be-tecknar en väteatom, och väri R betecknar en väteatom, 10 omsätts vid behov med en förening med formeln VI RjHal (VI) väri Hai betecknar en halogenatom och Ri betecknar en rak-15 kedjad, förgrenad eller cyklisk, mättad eller omättad alk-ylradikal med högst 8 kolatomer, vilken möjligen är subs-tituerad med en alkoxikarbonylgrupp, vars alkoxidel inne-häller högst 8 kolatomer, eller Rx betecknar en bensyl-eller fenetylradikal, för erhällande av en förening med 20 formeln Ic CH-N-OR' ! V ·*-ο f l
25 Ri väri Ra och R' har ovan angivna betydelse, vilken förening vid behov omvandlas tili ett sait, eller vilken förening, i det fall, att Rx betecknar 30 en alkylradikal substituerad med en alkoxikarbonylgrupp, omsätts med ett hydrolyseringsmedel, för erhällande av en förening innehällande en karboxiradikal, vilken förening vid behov omvandlas tili ett sait, eller 87199 30 b) en förening med formeln V CH=NOR' (V) 5 väri R' har ovan angivna betydelse, omsätts med en förening med formeln VI för erhällande av en förening med formeln VII 10 <tT~ CH=N0R' WNJJ (VII) Ri Hai - 15 vilken förening omsätts med ett hydrogeneringsmedel för erhällande av en förening med formeln Ic aCH=N0R' iIc) l Ri väri R2 och R' har ovan angivna betydelse, vilken förening vid behov omvandlas tili ett sait, 25 eller vilken förening, i det fall, att Rx betecknar en alkylradikal substituerad med en alkoxikarbonylgrupp, omsätts med ett hydrolyseringsmedel för erhällande av en förening innehällande en karboxigrupp, vilken förening vid behov omvandlas tili ett sait, eller 30 c) en förening med formeln V \ |p CH=N0R' 35 (V) 3i 87199 väri R' har ovan angivna betydelse, omsätts med en för-ening med formeln VI för erhällande av en förening med formeln VII CH=NOR' I + (VII) Ra Hai - 10 vilken förening omsätts med ett hydrogeneringsmedel för erhällande av en förening med formeln Ic -- CH=N0R' dc) j-a , Ri vilken förening vid behov omvandlas tili ett sait.
2. Förfarande enligt patentkravet 1, k ä n n e -20 tecknat därav, att man framställer nägon av de föl- jande föreningarna med formeln I: 1-metyl-l, 2,5,6-tetrahydropyridin-3-karboxialdehyd-0-me-tyloxim; 1-etyl-l,2,5,6-tetrahydropyridin-3-karboxialdehyd-0-me-25 tyloxim; 1,2,5,6-tetrahydropyridin-3-karboxialdehyd-0-metyloxim; 1-propyl-1,2,5,6-tetrahydropyridin-3-karboxialdehyd-0-me-tyloxim; och 1-allyl-l, 2,5, 6-tetrahydropyridin-3-karboxialdehyd-0-me-30 tyloxim; samt deras salter och i synnerhet deras hydroklorider.
FI870842A 1986-02-27 1987-02-26 Förfarande för framställning av terapeutiskt användbara 1,2,5,6-tetrah ydropyridin-3-karboxialdoximderivat FI87199C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT19565/86A IT1191667B (it) 1986-02-27 1986-02-27 Derivati della 1,2,5,6-tetraidropiridin-3-carbossaldeide ossima,loro procedimento di preparazione e loro applicazione come farmaci
IT1956586 1986-02-27
IT2115786 1986-07-17
IT21157/86A IT1196510B (it) 1986-07-17 1986-07-17 Derivati della 1,2-5,6-tetraidropiridin-3-carbossaldeide ossima,loro procedimento di preparazione e loro applicazione come farmaci

Publications (4)

Publication Number Publication Date
FI870842A0 FI870842A0 (fi) 1987-02-26
FI870842A FI870842A (fi) 1987-08-28
FI87199B true FI87199B (fi) 1992-08-31
FI87199C FI87199C (sv) 1992-12-10

Family

ID=26327212

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870842A FI87199C (sv) 1986-02-27 1987-02-26 Förfarande för framställning av terapeutiskt användbara 1,2,5,6-tetrah ydropyridin-3-karboxialdoximderivat

Country Status (20)

Country Link
US (3) US5219872A (sv)
EP (1) EP0239445B1 (sv)
JP (1) JPH07599B2 (sv)
KR (1) KR950005197B1 (sv)
AT (1) ATE76066T1 (sv)
AU (1) AU588972B2 (sv)
BG (1) BG61120B2 (sv)
CA (1) CA1327803C (sv)
DE (1) DE3778951D1 (sv)
DK (1) DK167803B1 (sv)
ES (1) ES2032456T3 (sv)
FI (1) FI87199C (sv)
GR (1) GR3004845T3 (sv)
HK (1) HK29797A (sv)
HU (1) HU198018B (sv)
IE (1) IE59095B1 (sv)
IL (1) IL81610A (sv)
NO (1) NO172180C (sv)
NZ (1) NZ219416A (sv)
PT (1) PT84366B (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786648A (en) * 1986-12-08 1988-11-22 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
US4710508A (en) * 1986-12-08 1987-12-01 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
US4798841A (en) * 1987-03-31 1989-01-17 Warner-Lambert Company Tetrahydropyridine oxime cholinergic agents and method of treatment
IT1203971B (it) * 1987-04-24 1989-02-23 Roussel Maestretti Spa Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti
IT1222526B (it) * 1987-08-21 1990-09-05 Roussel Maestretti Spa Derivati dell' ossima della 1,2,5,6-tetraidropiridin-3-carbossaldeide,loro procedimento di preparazione e loro impiego come sostanze medicinali
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
IT1233446B (it) * 1987-12-30 1992-04-01 Roussel Maestretti Spa Derivati della 3 piperidinocarbaldeide ossima, loro procedimento di preparazione e loro applicazione come farmaci
US5110828A (en) * 1988-04-15 1992-05-05 Beecham Group P.L.C. Azabicyclo oxime derivatives
EP0392803B1 (en) * 1989-04-13 2004-06-16 Beecham Group p.l.c. Novel compounds
US5278170A (en) * 1989-04-13 1994-01-11 Beecham Group P.L.C. Azabicylo oxime compounds
IT1240603B (it) * 1990-03-14 1993-12-17 Roussel Maestretti Spa Derivati della 1,2,5,6-tetraidropiridina 3- carbossaldeide ossima, loro procedimento di preparazione e loro impiego come sostanza medicinale
IT1241138B (it) * 1990-05-15 1993-12-29 Roussel Pharma Derivati dell'ossina della 1,2,5,6- tetraidropiridin-3-carbossaldeide,loro procedimento di preparazione e loro impiego come sostanze medicinali
IE912974A1 (en) * 1990-08-24 1992-02-26 Beecham Group Plc Novel compounds
GB9019095D0 (en) * 1990-09-01 1990-10-17 Beecham Group Plc Novel compounds
EP0552213A1 (en) * 1990-10-12 1993-07-28 Beecham Group Plc 1,2,5,6-tetrahydropyridine oxime derivatives
WO1993011767A1 (en) * 1991-12-18 1993-06-24 Warner-Lambert Company Transdermal delivery of (e)-1,2,5,6-tetrahydro-1-methyl-3-pyridine-carboxaldehyde-o-methyloxine hcl and related compounds in the treatment of cognitive disorders and for analgesia
ZA937382B (en) * 1992-10-06 1994-04-29 Warner Lambert Co Novel composition for peroral therapy of cognitionimpairment and a process therefor
WO1994007493A1 (en) * 1992-10-06 1994-04-14 Warner-Lambert Company Stabilized compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o-methyl-oxime
US5424301A (en) * 1993-02-01 1995-06-13 Warner-Lambert Company Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents
US5731314A (en) * 1995-01-06 1998-03-24 Bencherif; Merouane Pharamceutical compositions for prevention and treatment of tourette's syndrome
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US6455648B1 (en) 1999-12-29 2002-09-24 Chevron Phillips Chemical Company Lp Olefin production
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US9877500B2 (en) * 2007-03-14 2018-01-30 Concentrate Manufacturing Company Of Ireland Natural beverage products
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CH704993A1 (fr) 2011-05-20 2012-11-30 Bacab S A Câble électrique.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004979A (en) * 1961-10-17 Oximes of certain tetrahydropyridine
FR1258847A (fr) * 1960-02-12 1961-04-21 Ciba Geigy Procédé de préparation de nouveaux dérivés pyridiniques, entre autres de l'oxime de la l-méthyl-3 ou 4-acétyl-1, 2, 5, 6-tétrahydropyridine
US4786648A (en) * 1986-12-08 1988-11-22 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
US4710508A (en) * 1986-12-08 1987-12-01 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
IT1203971B (it) * 1987-04-24 1989-02-23 Roussel Maestretti Spa Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti

Also Published As

Publication number Publication date
ATE76066T1 (de) 1992-05-15
NZ219416A (en) 1989-04-26
KR870007890A (ko) 1987-09-22
DK98787A (da) 1987-08-28
GR3004845T3 (sv) 1993-04-28
IE870497L (en) 1987-08-27
NO870771L (no) 1987-08-28
HU198018B (en) 1989-07-28
NO172180C (no) 1993-06-16
PT84366B (pt) 1989-10-04
JPH07599B2 (ja) 1995-01-11
DE3778951D1 (de) 1992-06-17
BG61120B2 (bg) 1996-11-29
IL81610A (en) 1990-12-23
FI87199C (sv) 1992-12-10
FI870842A (fi) 1987-08-28
KR950005197B1 (ko) 1995-05-19
US5532375A (en) 1996-07-02
AU6927987A (en) 1987-09-03
CA1327803C (en) 1994-03-15
US5219872A (en) 1993-06-15
PT84366A (en) 1987-03-01
EP0239445A2 (fr) 1987-09-30
NO172180B (no) 1993-03-08
HK29797A (en) 1997-03-21
DK167803B1 (da) 1993-12-20
ES2032456T3 (es) 1993-02-16
DK98787D0 (da) 1987-02-26
IE59095B1 (en) 1994-01-12
EP0239445A3 (en) 1989-01-18
JPS62252767A (ja) 1987-11-04
IL81610A0 (en) 1987-09-16
AU588972B2 (en) 1989-09-28
NO870771D0 (no) 1987-02-25
US5391754A (en) 1995-02-21
FI870842A0 (fi) 1987-02-26
HUT44497A (en) 1988-03-28
EP0239445B1 (fr) 1992-05-13

Similar Documents

Publication Publication Date Title
FI87199B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,2,5,6-tetrahydropyridin-3 -karboxialdoximderivat.
FI66604C (fi) Foerfarande foer framstaellning av nya 5h-2,3-bensodiazepinderivat med inverkan pao det centrala nervsystemet
JPS6340792B2 (sv)
FI93211C (sv) Förfarande för framställning av nya, terapeutiskt användbara 1,2,5,6-tetrahydropyridinderivat
KR100488095B1 (ko) 1H-피리도(3,4-b)인돌-4-카르복사미드 유도체, 그의 제법 및치료에의 응용
US5015655A (en) 1-azabicycloalkane derivatives, their preparation process and their use as medicaments
KR960014998B1 (ko) 1,2,5,6-테트라히드로피리딘-3-카르복스알데히드의 옥심유도체, 이들의 제조방법, 약제로서의 이들의 용도 및 이들을 함유하는 조성물
EP0308284B1 (fr) Dérivés de l&#39;oxime du 1,2,5,6-tétrahydropyridine, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant
JP2750869B2 (ja) 三環式縮合ピリミジン誘導体
US4927837A (en) Derivatives of 3-piperidine carbaldehyde oxime and their use as medicaments
DE69011901T2 (de) 1-Arylsulfonyl-2-piperidinon-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende Zusammensetzungen.
EP0305298B1 (fr) Nouvelles imidazo benzodiazépines et leurs sels d&#39;addition avec les acides, leur procédé et les intermédiaires de préparation, leur application comme médicaments et les compositions les renfermant
US5183893A (en) 1-azabicycloalkane derivatives, their preparation process and their use as medicaments
US5231107A (en) Derivatives of the oxime of 1,2,5,6-tetrahydropyridine 3-carboxaldehyde, the process for their preparation, their use as medicaments and the compositions containing them
FR2606409A1 (fr) Derives d&#39;imidazopyridine, leur preparation et leur application en therapeutique
JACQUIGNON et al. Some 2, 3-Polymethylene-indoles and-quinolines. An Attempt to Synthesize Large-Ring Nitrogen Heterocycles
EP0452170A1 (fr) Dérivés du 1,2,5,6-tÀ©trahydropyridin-3-carboxaldéhyde oxime, leur procédé de préparation et leur application comme médicaments
JPS63166887A (ja) 新規なチアゾロ〔3,2−a〕ピリミジン誘導体

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: HOECHST MARION ROUSSEL

MM Patent lapsed

Owner name: AVENTIS PHARMA S.A.